Urinary Bladder Cancer: Biomarkers and Target Therapy, New Era for More Attention

Currently, bladder cancer (BCa) evaluation depends mainly on traditional clinicopathological parameters encompassing tumor stage and grade, which will not reflect the behavior of the disease. Diverse molecular alterations are responsible for the heterogeneous course. The differences in molecular pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Amrallah A., EL-Tanni, Hani, EL-Khatib, Hani M., Mirza, Ahmad A., Mirza, Abdulrahim A., Alturaifi, Turki H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178843/
https://www.ncbi.nlm.nih.gov/pubmed/28058098
http://dx.doi.org/10.4081/oncol.2016.320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178843/
https://www.ncbi.nlm.nih.gov/pubmed/28058098
http://dx.doi.org/10.4081/oncol.2016.320

Ejemplares similares